Disease-Modifying Antirheumatic Drug Market

It refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
Disease-Modifying Antirheumatic Drug Market contains market size and forecasts of Disease-Modifying Antirheumatic Drug in global, including the following market information:
Global Disease-Modifying Antirheumatic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Disease-Modifying Antirheumatic Drug Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Disease-Modifying Antirheumatic Drug companies in 2021 (%)
The global Disease-Modifying Antirheumatic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Steroidal Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Disease-Modifying Antirheumatic Drug include AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck and UCB S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Disease-Modifying Antirheumatic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Disease-Modifying Antirheumatic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Type, 2021 (%)
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
Global Disease-Modifying Antirheumatic Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Industry
Hospital and Clinic
Other
Global Disease-Modifying Antirheumatic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Disease-Modifying Antirheumatic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Disease-Modifying Antirheumatic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Disease-Modifying Antirheumatic Drug revenues share in global market, 2021 (%)
Key companies Disease-Modifying Antirheumatic Drug sales in global market, 2017-2022 (Estimated), (MT)
Key companies Disease-Modifying Antirheumatic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company